CardioVascular and Interventional Radiology

, Volume 41, Issue 3, pp 366–376 | Cite as

Modern Techniques of Lymphangiography and Interventions: Current Status and Future Development



One of the crucial functions of the lymphatic system is maintenance of fluid balance. Nonetheless, due to lack of clinical imaging and interventional techniques, the lymphatic system has been under the radar of the medical community. The recently developed intranodal lymphangiography and dynamic contrast-enhanced MR lymphangiography provide new insight into lymphatic pathology. Thoracic duct embolization has become the method of choice for the treatment of patients with chylous leaks. Interstitial lymphatic embolization further expanded the lymphatic embolization approaches. Liver lymphatic lymphangiography and embolization allow treatment of postsurgical liver lymphorrhea and protein-losing enteropathy. The potential for further growth of lymphatic interventions is vast and includes liver lymphatic procedures and advanced thoracic duct interventions, such as thoracic duct externalization and stenting. These current and future advances will open up a realm of new treatments and diagnostic opportunities.


Lymphatic disorders Lymphangiography Embolization MR lymphangiography 


Compliance with Ethical Standards

Conflict of interest

Maxim Itkin: Guerbet Group research support and speaking engagement. Gregory Nadolski: Research Support Guerbet group.

Ethical Approval Statement

This article does not contain any studies with human participants or animals performed by any of the authors.


  1. 1.
    Blalock A, Burwell CS. Thoracic duct lymph pressure in concretio cordis. J Lab Clin Med. 1935;1:296–7.Google Scholar
  2. 2.
    Guyton AC. Interstitial fluid pressure and dynamics of lymph formation. Introduction. Fed Proc. 1976;35:1861–2.PubMedGoogle Scholar
  3. 3.
    DeBenedetti MJ, Wright PW, Orloff MJ. Dynamics of hepatic lymph and blood flow in experimental liver disease and ascites. Surg Forum. 1965;16:274–6.PubMedGoogle Scholar
  4. 4.
    Ikomi F, Kawai Y, Ohhashi T. Recent advance in lymph dynamic analysis in lymphatics and lymph nodes. Ann Vasc Dis. 2012;5:258–68.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Morris B. The exchange of protein between the plasma and the liver and intestinal lymph. Q J Exp Physiol Cogn Med Sci. 1956;41:326–40.PubMedGoogle Scholar
  6. 6.
    Yoffey JM, Courtice FC. Lymphatics, lymph and the lymphomyeloid complex. London: Academic; 1970.Google Scholar
  7. 7.
    Davis HK. A statistical study of the thoracic duct in man. Am J Anat. 1914;17:2011–244.Google Scholar
  8. 8.
    Kausel HW, Reeve TS, Stein AA, Alley RD, Stranahan A. Anatomic and pathologic studies of the thoracic duct. J Thorac Surg. 1957;34:631–41.PubMedGoogle Scholar
  9. 9.
    Guermazi A, Brice P, Hennequin C, Sarfati E. Lymphography: an old technique retains its usefulness. Radiographics. 2003;23:1541–60.CrossRefPubMedGoogle Scholar
  10. 10.
    Peterss S, Gratz KF, Khaladj N, Hagl C, Warnecke G, Fischer S, et al. Lymphoscintigraphic localization of a high-output chylus leak after bilateral lung transplantation. J Heart Lung Transpl. 2011;30:481–3.CrossRefGoogle Scholar
  11. 11.
    Cope C, Kaiser LR. Management of unremitting chylothorax by percutaneous embolization and blockage of retroperitoneal lymphatic vessels in 42 patients. J Vasc Interv Radiol. 2002;13:1139–48.CrossRefPubMedGoogle Scholar
  12. 12.
    Nadolski GJ, Itkin M. Thoracic duct embolization for nontraumatic chylous effusion: experience in 34 patients. Am Coll Chest Phys. 2013;143:158–63. Chest [Internet].Google Scholar
  13. 13.
    Itkin M, Kucharczuk JC, Kwak A, Trerotola SO, Kaiser LR. Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg. 2010;139:584–90.CrossRefPubMedGoogle Scholar
  14. 14.
    Itkin M, Piccoli DADA, Nadolski G, Rychik J, DeWitt A, Pinto E, et al. Protein-losing enteropathy in patients with congenital heart disease. J Am Coll Cardiol. 2017;69:2929–37.CrossRefPubMedGoogle Scholar
  15. 15.
    Cope C. Usefulness of a percutaneous transhepatic coaxial micropuncture needle technique in patients with nondilated peripheral intrahepatic ducts. Am J Roentgenol. 2003;181:1017–20.CrossRefGoogle Scholar
  16. 16.
    Gabler WL, Fosdick LS. Flow rate and composition of thoracic duct lymph with and without cisterna chyle ligation. Proc Soc Exp Biol Med. 1964;115:915–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Fish JC, Sarles HE, Remmers A, Townsend CM, Bell JD, Flye MW. Renal transplantation after thoracic duct drainage. Ann Surg. 1981;193:752–6.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Machleder HI, Paulus H. Clinical and immunological alterations observed in patients undergoing long-term thoracic duct drainage. Surgery. 1978;84:157–65.PubMedGoogle Scholar
  19. 19.
    Wegelius O, Laine V, Lindström B, Klockars M. Fistula of the thoracic duct as immunosuppressive treatment in rheumatoid arthritis. Acta Med Scand. 1970;187:539–44.CrossRefPubMedGoogle Scholar
  20. 20.
    Bonomini V, Mioli V, Albertazzi A, Vangelista A. Immunosuppressive drugs and lymphatic depletion by thoracic duct fistula in adult progressive glomerulonephritis. Nephron. 1970;7:389–99.CrossRefPubMedGoogle Scholar
  21. 21.
    Ravnskov U, Dahlbäck O, Messeter L. Treatment of glomerulonephritis with drainage of the thoracic duct and plasmapheresis. Acta Med Scand. 1977;202:489–94.CrossRefPubMedGoogle Scholar
  22. 22.
    Nyman KE, Bangert R, Machleder H, Paulus HE. Thoracic duct drainage in SLE with cutaneous vasculitis. Arthritis Rheum. 1977;20:1129–34.CrossRefPubMedGoogle Scholar
  23. 23.
    Bergström K, Franksson C, Matell G, Nilsson BY, Persson A, von Reis G, et al. Drainage of thoracic duct lymph in twelve patients with myasthenia gravis. Eur Neurol. 1975;13:19–30.CrossRefPubMedGoogle Scholar
  24. 24.
    Ring J, Seifert J, Lob G, Coulin K, Angstwurm H, Frick E, et al. Intensive immunosuppression in the treatment of multiple sclerosis. Lancet. 1974;2:1093–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Sarles HE, Remmers AR, Fish JC, Canales CO, Thomas FD, Tyson KR, et al. Depletion of lymphocytes for the protection of renal allografts. Arch Intern Med. 1970;125:443–50.CrossRefPubMedGoogle Scholar
  26. 26.
    Wang H-W, Escott ABJ, Phang KL, Petrov MS, Phillips ARJ, Windsor JA, et al. Indications, techniques, and clinical outcomes of thoracic duct interventions in patients: a forgotten literature? J Surg Res. 2016;204:213–27.CrossRefPubMedGoogle Scholar
  27. 27.
    Cole WR, Witte MH, Kash SL, Rodger M, Bleisch VR, Muelheims GH. Thoracic duct-to-pulmonary vein shunt in the treatment of experimental right heart failure. Circulation. 1967;36:539–43.CrossRefPubMedGoogle Scholar
  28. 28.
    Witte MH, Dumon AE, Clauss RH, Rader B, Levine N, Breed ES. Lymph circulation in congestive heart failure: effect of external thoracic duct drainage. Circulation. 1969;39:723–33.CrossRefPubMedGoogle Scholar
  29. 29.
    Dumont AE, Clauss RH, DA Reed GET. Lymph drainage in patients with congestive heart failure: comparison with findings in hepatic cirrhosis. N Engl J Med. 1963;269:949–52.CrossRefPubMedGoogle Scholar
  30. 30.
    Deitch EA. Gut-origin sepsis: evolution of a concept. Surgeon. 2012;10:350–6.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Fanous MYZ, Phillips AJ, Windsor JA. Mesenteric lymph: the bridge to future management of critical illness. JOP. 2007;8:374–99.PubMedGoogle Scholar
  32. 32.
    Dugernier TL, Laterre PF, Wittebole X, Roeseler J, Latinne D, Reynaert MS, et al. Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. Am J Respir Crit Care Med. 2003;168:148–57.CrossRefPubMedGoogle Scholar
  33. 33.
    Brzek V, Bartos V. Therapeutic effect of the prolonged thoracic duct lymph fistula in patients with acute pancreatitis. Digestion. 1969;2:43–50.CrossRefPubMedGoogle Scholar
  34. 34.
    Witte MH, Horowitz L, Dumont AE. Use of thoracic-duct cannulation in the diagnosis of tuberculous enteritis. N Engl J Med. 1963;268:1125–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Lim WA, June CH. The principles of engineering immune cells to treat cancer. Cell. 2017;168:724–40.CrossRefPubMedGoogle Scholar
  36. 36.
    Baek Y, Won JH, Chang SJ, Ryu HS, Song S-Y, Yim B, et al. Lymphatic embolization for the treatment of pelvic lymphoceles: preliminary experience in five patients. J Vasc Interv Radiol. 2016;27:1170–6.CrossRefPubMedGoogle Scholar
  37. 37.
    Hur S, Shin JH, Lee IJ, Min SK, Min SI, Ahn S, et al. Early experience in the management of postoperative lymphatic leakage using lipiodol lymphangiography and adjunctive glue embolization. J Vasc Interv Radiol. 2016;27(1177–1186):e1.Google Scholar
  38. 38.
    Chick JFB, Dori Y, Itkin M. Single-session endolymphatic glue embolization of lymphocele after heart transplantation. J Vasc Interv Radiol. 2016;27:929–30.CrossRefPubMedGoogle Scholar
  39. 39.
    Weaver MV, Tadros RO, Phangureh VS, Faries PL, Lookstein RA, Marin ML. A novel approach to the management of a recurrent lymphocele following a femoral-femoral bypass. J Vasc Surg Soc Vasc Surg. 2013;59:1109–11.CrossRefGoogle Scholar
  40. 40.
    Mahrer A, Ramchandani P, Trerotola SO, Shlansky-Goldberg RD, Itkin M. Sclerotherapy in the management of postoperative lymphocele. J Vasc Interv Radiol. 2010;21:1050–3.CrossRefPubMedGoogle Scholar
  41. 41.
    Starling EH. The Influence of mechanical factors on lymph production. J Physiol. 1894;16:224–67.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Ohtani O, Ohtani Y. Lymph Circulation in the Liver. Anat. Rec. (Hoboken, NJ 2007). Wiley Subscription Services, Inc., A Wiley Company; 2008; 291:643–52.Google Scholar
  43. 43.
    Cain JC, Grindlay JH. Lymph from liver and thoracic duct; an experimental study. Surg Gynecol Obstet. 1947;85:558–62.PubMedGoogle Scholar
  44. 44.
    Barrowman JA, Granger DN. Effects of experimental cirrhosis on splanchnic microvascular fluid and solute exchange in the rat. Gastroenterology. 1984;87:165–72.PubMedGoogle Scholar
  45. 45.
    Nix JT, Flock EV, Bollman JL. Influence of cirrhosis on proteins of cisternal lymph. Am J Physiol. 1951;164:117–8.PubMedGoogle Scholar
  46. 46.
    Dumont AE, Mulholland JH. Flow rate and composition of thoracic-duct lymph in patients with cirrhosis. N Engl J Med. 1960;263:471–4.CrossRefPubMedGoogle Scholar
  47. 47.
    Rabin AM, Abramson AF, Manzarbeitia C, Mitty HA, Miller CM, Train JS, et al. Dilated periportal lymphatics mimicking an anastomotic bile leak after liver transplantation. Gastrointest Radiol. 1991;16:337–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Marincek B, Barbier PA, Becker CD, Mettler D, Ruchti C. CT appearance of impaired lymphatic drainage in liver transplants. Am J Roentgenol. 1986;147:519–23.CrossRefGoogle Scholar
  49. 49.
    Chung C, Iwakiri Y. The lymphatic vascular system in liver diseases: its role in ascites formation. Clin Mol Hepatol. 2013;19:99–104.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Hawkins IF, Cho KJ, Fiola F, Medina JA, Morelli G, Caridi JG. False-positive “Cavernous Transformation” secondary to lymphatic filling in parenchymal hepatic CO2 injection for portal vein visualization in TIPS procedures. J Vasc Interv Radiol. 2009;20:600–5.CrossRefPubMedGoogle Scholar
  51. 51.
    Okuda K, Sumikoshi T, Kanda Y, Fukuyama Y, Koen H. Hepatic lymphatics as opacified by percutaneous intrahepatic injection of contrast medium. Analysis of hepatic lymphograms in 125 cases. Radiology. 1976;120:321–6.CrossRefPubMedGoogle Scholar
  52. 52.
    Goldberg HI, Dodds WJ, Lawson TL, Stewart ET, Moss AA. Hepatic lymphatics demonstrated by percutaneous transhepatic cholangiography. Am J Roentgenol Radium Ther Nucl Med. 1975;123:415–9.CrossRefPubMedGoogle Scholar
  53. 53.
    Baggenstoss AH, Cain J. The hepatic hilar lymphatics of man; their relation to ascites. N Engl J Med. 1957;256:531–5.CrossRefPubMedGoogle Scholar
  54. 54.
    Ludwig J, Linhart P, Baggenstoss AH. Hepatic lymph drainage in cirrhosis and congestive heart failure. A postmortem lymphangiographic study. Arch Pathol. 1968;86:551–62.PubMedGoogle Scholar
  55. 55.
    Moreno AH, Rousselot LM, Burchell AR, Bong RF, Burke JH. Studies on the outflow tracts of the liver. I. On a method for the functional demonstration of the outflow tracts of the liver and its application to the study of hepatic hemodynamics in normal and cirrhotic rats. Ann Surg. 1962;155:412–26.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Moreno AH, Ruzicka FF, Rousselot LM, Burchell AR, Bono RF, Slafsky SF, et al. Functional Hepatography. Radiol Radiol Soc N Am. 1963;81:65–79.Google Scholar
  57. 57.
    Clain D, McNulty J. A radiological study of the lymphatics of the liver. Br J Radiol. 1968;41:662–8.CrossRefPubMedGoogle Scholar
  58. 58.
    Sezai S, Sakurabayashi S, Yamamoto Y, Hirano M, Kamisaka K. OKA H. Percutaneous transhepatic lymphography (PTL) for visualizing metastasized lesions from hepatocellular carcinoma. Int Hepatol Commun. 1994;2:1–5.CrossRefGoogle Scholar
  59. 59.
    Guez D, Nadolski GJ, Pukenas BA, Itkin M. Transhepatic lymphatic embolization of intractable hepatic lymphorrhea. J Vasc Interv Radiol. 2014;25:149–50.CrossRefPubMedGoogle Scholar
  60. 60.
    Matsumoto S, Mori H, Tada I. Successful demonstration of post-operative lymphatic fistula by percutaneous transhepatic lymphography. Clin Radiol. 2000;55:485–6.CrossRefPubMedGoogle Scholar
  61. 61.
    Dumont AE. The flow capacity of the thoracic duct-venous junction. Am J Med Sci. 1975;269:292–301.CrossRefPubMedGoogle Scholar
  62. 62.
    Donini I, Bresadola F. Cervical lymph-venous shunt in experimental ascites and in patients with hepatic cirrhosis. Lymphology. 1974;7:105–8.PubMedGoogle Scholar
  63. 63.
    Aboul-Enein A. Thoracic duct decompression by side to end anastomosis to external jugular vein. J Cardiovasc Surg (Torino). 1980;21:574–7.Google Scholar
  64. 64.
    Bhalerao RA, Trivedi DR, Sen PK. Lymphovenous anastomosis in the management of portal hypertension. Surgery. 1971;69:569–76.PubMedGoogle Scholar
  65. 65.
    Puttini M, Palmieri B, Belli L. A critical re-appraisal of lymph-venous shunt in the management of massive ascites. J Cardiovasc Surg (Torino). 1984;25:126–9.Google Scholar
  66. 66.
    Dahlqvist GE, Jamar F, Zech F, Geubel AP. In-111 transferrin scintigraphy in cirrhosis with hypoalbuminemia: Evidence for protein-losing enteropathy in a small group of selected cases. Scand J Gastroenterol. 2012;47:1247–52.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017

Authors and Affiliations

  1. 1.HUP/CHOP Center for Lymphatic Imaging and Interventions, Penn MedicineChildren’s Hospital of PhiladelphiaPhiladelphiaUSA

Personalised recommendations